Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy

Vinod Kumar1, Raja Ramachandran1, Ashwani Kumar2

  • 1Department of Nephrology, Postgraduate Institute of Medical Education & Research, Chandigarh, India.

Insights

Idiopathic membranous nephropathy (IMN) in children is rare, but this study found phospholipase A2 receptor (PLA2R) antibodies in 60% of cases. Reduced antibody levels correlated with decreased proteinuria, suggesting PLA2R

Area of Science:

  • Nephrology
  • Immunology
  • Pediatrics

Background:

  • Idiopathic membranous nephropathy (IMN) is the leading cause of nephrotic syndrome (NS) in adults, but less common in children.
  • Antibodies to the phospholipase A2 receptor (PLA2R) are detected in a majority of adult IMN cases.
  • Previous studies show PLA2R staining in glomerular deposits in both adult and pediatric IMN, but anti-PLA2R antibodies have not been reported in pediatric IMN.

Purpose of the Study:

  • To investigate the presence and role of anti-PLA2R antibodies and PLA2R in pediatric IMN.
  • To determine if anti-PLA2R antibodies contribute to the pathogenesis of IMN in children.

Main Methods:

  • Retrospective analysis of five pediatric IMN cases.
  • Evaluation of anti-PLA2R antibody titers.
  • Immunohistochemical staining for PLA2R in kidney biopsy glomerular deposits.

Main Results:

  • All five pediatric IMN cases showed PLA2R staining in glomeruli.
  • Anti-PLA2R antibodies were detected in three out of five (60%) pediatric cases.
  • A parallel reduction in proteinuria and anti-PLA2R antibody titers was observed.

Conclusions:

  • PLA2R appears to play a role in the pathogenesis of pediatric IMN.
  • The findings suggest that anti-PLA2R antibodies may be relevant in pediatric IMN, similar to adult cases.
  • Further research is warranted to confirm these findings and explore therapeutic implications.

Related Concept Videos